ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 156 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $326,000 | -38.1% | 6,291 | -15.0% | 0.01% | -40.0% |
| Q1 2022 | $527,000 | +3.9% | 7,399 | +9.1% | 0.01% | -23.1% |
| Q4 2021 | $507,000 | +113.9% | 6,779 | +62.6% | 0.01% | +225.0% |
| Q3 2021 | $237,000 | -37.8% | 4,169 | -51.9% | 0.00% | -42.9% |
| Q2 2021 | $381,000 | +28.3% | 8,664 | +44.1% | 0.01% | +40.0% |
| Q1 2021 | $297,000 | -61.1% | 6,012 | -64.0% | 0.01% | -78.3% |
| Q3 2020 | $764,000 | -30.5% | 16,698 | -23.8% | 0.02% | -56.6% |
| Q2 2020 | $1,100,000 | – | 21,916 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
| GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
| ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
| Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
| Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
| Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
| 361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
| ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
| AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |